These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26189304)

  • 1. Incidence of potential drug-drug interactions with antidiabetic drugs.
    Samardzic I; Bacic-Vrca V
    Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of potential drug-drug interactions in diabetic out-patients in a tertiary care teaching hospital in Nepal.
    Dinesh KU; Subish P; Pranaya M; Shankar PR; Anil SK; Durga B
    Med J Malaysia; 2007 Oct; 62(4):294-8. PubMed ID: 18551932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC; Quilliam BJ
    Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
    Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
    Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation).
    Kogut SJ; Andrade SE; Willey C; Larrat EP
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):591-8. PubMed ID: 15362081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of potential drug- drug interactions in hospitalized patients with type 2 diabetes mellitus in China: a retrospective study.
    Ren W; Liu Y; Jiang H; Lv X; Zhang N
    Front Endocrinol (Lausanne); 2024; 15():1387242. PubMed ID: 38982988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.
    Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Trends Pharmacol Sci; 2012 Jun; 33(6):312-22. PubMed ID: 22475684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
    Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
    Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population.
    Goldberg RM; Mabee J; Chan L; Wong S
    Am J Emerg Med; 1996 Sep; 14(5):447-50. PubMed ID: 8765105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
    Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
    Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinically significant drug-drug interactions in prescribed pharmacotherapy in an outpatient setting.
    Samardžić I; Marinović I; Kuča N; Vrca VB
    Pharmazie; 2021 Aug; 76(8):390-395. PubMed ID: 34412739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.